NasdaqCM - Nasdaq Real Time Price USD

Nuwellis, Inc. (NUWE)

Compare
1.5200 -0.0700 (-4.46%)
As of 12:33 PM EDT. Market Open.
Loading Chart for NUWE
DELL
  • Previous Close 1.5900
  • Open 1.3700
  • Bid 1.4600 x 400
  • Ask 1.5600 x 400
  • Day's Range 1.3500 - 1.6800
  • 52 Week Range 1.0000 - 43.7500
  • Volume 688,535
  • Avg. Volume 700,062
  • Market Cap (intraday) 2.838M
  • Beta (5Y Monthly) 0.42
  • PE Ratio (TTM) --
  • EPS (TTM) -120.9600
  • Earnings Date Nov 5, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 16.00

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

www.nuwellis.com

59

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NUWE

View More

Performance Overview: NUWE

Trailing total returns as of 10/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NUWE
92.51%
S&P 500
21.35%

1-Year Return

NUWE
96.50%
S&P 500
33.50%

3-Year Return

NUWE
99.98%
S&P 500
31.81%

5-Year Return

NUWE
100.00%
S&P 500
98.27%

Compare To: NUWE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NUWE

View More

Valuation Measures

Annual
As of 7/12/2024
  • Market Cap

    2.97M

  • Enterprise Value

    2.60M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.03

  • Price/Book (mrq)

    2.58

  • Enterprise Value/Revenue

    0.29

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -232.24%

  • Return on Assets (ttm)

    -79.49%

  • Return on Equity (ttm)

    -987.45%

  • Revenue (ttm)

    9.01M

  • Net Income Avi to Common (ttm)

    -22.81M

  • Diluted EPS (ttm)

    -120.9600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.02M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -12.32M

Research Analysis: NUWE

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 2.19M
Earnings -7.72M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

16.00
16.00 Average
1.5200 Current
16.00 High
 

Company Insights: NUWE

People Also Watch